Meta-analysis identifies four new loci associated with testicular germ cell tumor
- PMID: 23666239
- PMCID: PMC3723930
- DOI: 10.1038/ng.2634
Meta-analysis identifies four new loci associated with testicular germ cell tumor
Abstract
We conducted a meta-analysis to identify new susceptibility loci for testicular germ cell tumor (TGCT). In the discovery phase, we analyzed 931 affected individuals and 1,975 controls from 3 genome-wide association studies (GWAS). We conducted replication in 6 independent sample sets comprising 3,211 affected individuals and 7,591 controls. In the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E. These new TGCT susceptibility loci contain biologically plausible genes encoding proteins important for male germ cell development, chromosomal segregation and the DNA damage response.
Conflict of interest statement
There are no conflicts of interest.
Figures




Comment in
-
Testicular cancer: New studies identify susceptibility loci, implicated genes.Nat Rev Urol. 2013 Jul;10(7):370. doi: 10.1038/nrurol.2013.121. Epub 2013 May 28. Nat Rev Urol. 2013. PMID: 23712200 No abstract available.
References
-
- Rosen A, Jayram G, Drazer M, Eggener SE. Global trends in testicular cancer incidence and mortality. Eur Urol. 2011;60:374–9. - PubMed
-
- Howlader N, et al. SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) based on November 2011 SEER data submission, posted to the SEER web site, 2012. National Cancer Institute; Bethesda MD: 2012.
Publication types
MeSH terms
Supplementary concepts
Grants and funding
- P30 CA016672/CA/NCI NIH HHS/United States
- R01 CA102042/CA/NCI NIH HHS/United States
- R01 CA114478/CA/NCI NIH HHS/United States
- R01CA085914/CA/NCI NIH HHS/United States
- R01CA114478/CA/NCI NIH HHS/United States
- P30 ES013508/ES/NIEHS NIH HHS/United States
- R01CA102042/CA/NCI NIH HHS/United States
- U01 CA098758/CA/NCI NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- 10589/CRUK_/Cancer Research UK/United Kingdom
- HHSN261200655004C/PHS HHS/United States
- R01 CA085914/CA/NCI NIH HHS/United States
- P30 CA016520/CA/NCI NIH HHS/United States
- U01-CA98758/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous